Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear

Area of Science:

• Otolaryngology
• Regenerative Medicine
• Gene Therapy

Background:

• Age-related hearing loss, or sensorineural hearing loss, significantly impacts the elderly population.
• Current therapeutic options for hearing loss are limited, with minimal progress in effective treatments.
• Regenerating sensory cells in the inner ear is a key challenge for restoring hearing.

Purpose of the Study:

• To review current treatments for sensorineural hearing loss.
• To explore novel therapeutic strategies, focusing on gene-delivery technologies.
• To investigate the potential of gene therapy for inner ear sensory cell regeneration and clinical translation.

Main Methods:

• Review of existing literature on sensorineural hearing loss treatments.
• Analysis of in vitro and in vivo research on novel therapeutic techniques.
• Emphasis on gene-delivery systems targeting inner ear sensory cell proliferation and differentiation.

Main Results:

• Identification of established practices for managing sensorineural hearing loss.
• Overview of emerging gene-delivery technologies for hearing restoration.
• Evaluation of the potential for these novel techniques to yield clinical benefits.

Conclusions:

• Gene-delivery technologies represent a promising frontier for treating hearing loss.
• Further research is needed to translate in vitro and in vivo findings into effective clinical therapies.
• Targeting inner ear sensory cell regeneration holds significant potential for future hearing loss interventions.